SCHEMBL5329080

SCHEMBL5329080

CCCCc1c(C)[nH]c2cc(-c3ccco3)nn2c1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.50
▸ KDM4E B2RXH2 3/20 0.47
▸ NPC1 O15118 2/20 0.47
▸ RAB9A P51151 2/20 0.47
▸ ADORA3 P0DMS8 3/20 0.42
▸ CNR2 P34972 3/20 0.40
▸ ALDH1A1 P00352 5/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ PDE10A Q9Y233 1/20 0.39
▸ PTGS2 P35354 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ ADORA2A P29274 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ GFER P55789 1/20 0.37
▸ APOBEC3G Q9HC16 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ USP2 O75604 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9423324 0.80 PARP1 (0.50) PARP1KDM4ENPC1RAB9AADORA3
SCHEMBL9207322 0.70 ALPI (0.55) PARP1KDM4ENPC1RAB9AALDH1A1
SCHEMBL23998523 0.69 PARP1 (0.58) PARP1KDM4EADORA3ALDH1A1PDE10A
SCHEMBL28990863 0.68 PARP1 (0.57) PARP1KDM4EADORA3ALDH1A1PDE10A
SCHEMBL4053642 0.67 PARP1 (1.00) PARP1ADORA3ADORA2A
SCHEMBL3431339 0.66 PARP1 (0.50) PARP1KDM4ENPC1RAB9AADORA3
SCHEMBL9208448 0.64 PDE6D (0.40) PARP1KDM4EADORA3ALDH1A1MEN1
SCHEMBL9213755 0.64 ALDH1A1 (0.48) PARP1KDM4ENPC1RAB9AALDH1A1
SCHEMBL23998512 0.63 ADORA3 (0.51) PARP1ADORA3ALDH1A1MEN1KMT2A
SCHEMBL20075842 0.62 NPC1 (0.50) KDM4ENPC1RAB9AADORA3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070148185-A1 Novel therapeutic target for protozoal diseases VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY 2007-06-28 — — US claimed
WO-2007047579-A2 A NOVEL THERAPEUTIC TARGET FOR PROTOZOAL DISEASES VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 2007-04-26 — — WO claimed
EP-1745021-A1 HYDROFORMYLATION PROCESS FOR PHARMACEUTICAL INTERMEDIATE The Dow Global Technologies Inc. (US) 2007-01-24 — — EP disclosed
WO-2005110986-A1 HYDROFORMYLATION PROCESS FOR PHARMACEUTICAL INTERMEDIATE DOW GLOBAL TECHNOLOGIES INC. (US) 2005-11-24 — — WO disclosed
Send feedback